Back to results
US 7,608,614 B2Granted
Process for preparing macrocyclic compounds
AssigneeBoehringer Ingelheim International GmbH
InventorsCarl Alan Busacca, Fabrice Gallou, Nizar Haddad, Azad Hossain, Suresh R. Kapadia, Jianxiu Liu, Chris Senanayake, Xudong Wei, Nathan K. Yee
Life of this patent
Estimating the term…
Abstract
Intermediates of the formula QUIN: and methods for their preparation are described. The intermediate compounds are useful for preparing active agents for the treatment of hepatitis C virus (HCV) infection.
Claims26
A compound of the following formula QUIN:
- wherein:
- L0 selected from H, —OH, —OCH3, —OC2H5, —OC3H7, —OCH(CH3)2, —NHCH3, —NHC2H5, —NHC3H7, —NHCH(CH3)2, —N(CH3)2, —N(CH3)C2H5, —N(CH3)C3H7 and —N(CH3)CH(CH3)2,
- L1 and L2 are each independently selected from hydrogen, fluorine, chlorine, bromine, —CH3, —C2H5, —C3H7, —CH(CH3)2, —OCH3, —OC2H5, —OC3H7 and —OCH(CH3)2,
- R2 is C1-6 thioalkyl, C1-6 alkoxy, or Het, where Het is selected from the following:
- wherein R6 is H, C1-6 alkyl, NH—R7, NH—C(O)—R7, or NH—C(O)—NH—R7,
- wherein each R7 is independently:
- H, C1-6 alkyl, or C3-6 cycloalkyl;
- or R6 is NH—C(O)—OR8, wherein R8 is C1-6 alkyl;
- and R is a C6 or C10 aryl group.
6 more elements
Dependencies are inferred from the claim text.